VOGLIKEM 0.3 10'S

About

Voglikem 0.3 contains voglibose, an alpha-glucosidase inhibitor, used in the management of type 2 diabetes mellitus. Voglibose works by reversibly inhibiting alpha-glucosidase enzymes in the small intestine, which are responsible for breaking down complex carbohydrates into absorbable monosaccharides. By slowing down the digestion and absorption of carbohydrates, voglibose effectively reduces the postprandial (after-meal) rise in blood glucose levels. This mechanism helps to flatten the glucose curve after meals, thereby improving overall glycemic control. It is particularly useful for patients whose blood glucose levels spike significantly after eating. Voglibose does not stimulate insulin secretion and therefore carries a low risk of hypoglycemia when used as monotherapy. It is often prescribed as an adjunct to diet and exercise, or in combination with other oral antidiabetic agents.

Uses

• Management of type 2 diabetes mellitus.
• To reduce postprandial hyperglycemia.
• As an adjunct to diet and exercise.
• In combination with other antidiabetic agents.

Directions For Use

Take orally immediately before or with the first bite of each main meal. Do not skip meals after taking the medication.

Benefits

• Effectively lowers postprandial blood glucose.
• Reduces HbA1c levels.
• Low risk of hypoglycemia as monotherapy.
• Does not cause weight gain.
• Improves overall glycemic control.
• Can be combined with other antidiabetic drugs.

Side Effects

• Flatulence
• Abdominal distension
• Diarrhea
• Abdominal pain
• Nausea
• Constipation
• Indigestion
• Headache
• Dizziness
• Skin rash (rare)
• Elevated liver enzymes (rare)
• Intestinal obstruction (rare)

Safety Measures

• Alcohol - Moderate alcohol consumption is generally acceptable, but excessive intake should be avoided as it can affect blood sugar levels.
• Pregnancy - Not recommended during pregnancy due to insufficient safety data. Consult your doctor for alternatives.
• Breastfeeding - Not advised during breastfeeding as it is unknown if voglibose passes into breast milk.
• Liver - Use with caution in patients with severe liver impairment. Regular monitoring of liver function tests may be required.
• Kidney - Use with caution in patients with severe renal impairment. Dose adjustment may be necessary.
• Lung - No specific contraindications related to lung conditions, but general caution applies in severe systemic illness.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.